INTELLIA THERAPEUTICS, INC. at Morgan Stanley Global Healthcare Conference Transcript
All right. Well, thanks, everyone, for joining us. I'm Terence Flynn, Morgan Stanley's US biopharma analyst. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.
So I'm very pleased to be hosting Intellia today. Joining us from the company, we have John Leonard, the company's CEO; and Ed Dulac, who's the company's CFO. Thank you both for being here. Really appreciate it. Looking forward to speaking with you.
Questions & Answers
I thought we'd start maybe just high level, John, to talk about in vivo editing and just the potential for the platform. I think, again, there's been a lot of -- the technology has been in development for a long time now. We're starting to see really impressive use cases here. And so as
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
